key: cord-0703552-4hlkxf7v
authors: Joishy, Suresh K.; Sadohara, Michito; Kurihara, Masaru; Tokuda, Yasuharu
title: Complexity of the Diagnosis of COVID-19 in the Context of Pandemicity: Need for Excellence in Diagnostic Acumen
date: 2022-01-20
journal: Korean J Fam Med
DOI: 10.4082/kjfm.20.0188
sha: 7c19cbd8b3202428f6c464015a2e82a31d2fb519
doc_id: 703552
cord_uid: 4hlkxf7v

Coronavirus disease 2019 (COVID-19) is a highly infectious disease that has caused a pandemic devastating many countries worldwide. It is a complex and multifaceted disease with a unique coronavirus etiology, pathogenesis, zoonotic, and human-to-human transmission, causing acute respiratory distress syndrome with high mortality. Accurate and timely diagnosis is of utmost importance. In this study, we discussed the complexities of COVID-19 diagnostic elements in the context of pandemicity, drawing from our awareness, observations, and lessons learned from two previous coronavirus pandemics, namely SARS-CoV (severe acute respiratory syndrome coronavirus) in 2002 and MERS-CoV (Middle East respiratory syndrome-related coronavirus) in 2012, and how they applied to the diagnosis of COVID-19 today. Diagnosis of COVID-19 takes place without physician-patient personal contact due to isolation or quarantine or in the hospital setting, emergency units, and critical care units with the cumbersome barriers of personal protective equipment. Technical diagnosis is important, but we also emphasized the human impact of diagnosing COVID-19. Conveying the diagnosis of a critical disease to patients and families requires aspects of excellence in professionalism: ethics, empathy, and humility. Diagnostic skills in COVID-19 should extend to prognostication for patients suffering at the end of life, so that they will not be deprived of high-quality palliative care and comfort.

Control. This is the most comprehensive study on COVID-19 available today, covering epidemiology, etiology, viral identification, gene sequencing, development of molecular testing by reverse transcriptasepolymerase chain reaction (RT-PCR), laboratory diagnosis, radiological imaging studies, pathogenesis of acute respiratory distress syndrome, hospital management, and outcomes. Equally importantly, they set guidelines for the control of the epidemic by testing, tracking, tracing, and syndromic containment by isolation and quarantine. At the time of writing, China, Singapore, and South Korea seem to have contained this pandemic. 3) We cite more scholarly reviews and guidelines in the discussion section. However, English literature reviews and discourses are overwhelmingly repetitive based on Chinese foundational work. Why then, this study on COVID-19? COVID-19 is a complex infectious disease that has caused a pandemic. Clinically, it can be benign, very mild to the most severe, and lethal. It is a systemic disease where processes, mechanisms, and molecules at multiple levels act simultaneously at non-acceptable, non-normal levels, as stated by Vihinen from Sweden. 4) There is a wide gap in the literature regarding the complexities of COVID-19 and diagnostic elements required for accurate and timely diagnosis without dilemmas and delays. We clarify the diagnostic elements of COVID-19 from our collective recall of clinical observations of previous coronavirus pandemics of this century, namely severe acute respiratory syndrome (SARS) 5) and Middle East respiratory syndrome (MERS). 6) In addition, the purpose of this study was to clarify how the diagnostic elements of mainstream diseases are affected by the complexities of COVID-19. We examined the pandemic aspects of COVID-19 through a diagnostic lens, and then generated a diagnostic triad-the virus, patients, and lungs-that determine the prognosis.

We describe the impact of the diagnosis, tangibles and intangibles, and the need for ethics and empathy. Finally, we propose to include diagnostic elements to recognize the physical, psychosocial, and spiritual issues and end-of-life palliative care until we have a cure or prophylaxis.

The database in the literature on diagnosis and diagnostics is huge, with reviews and guidelines. Wu and McGoogan. 2) presented a review of 72,314 patients from China. Borges do Nascimento et al. 7) conducted a scoping review and meta-analysis of 61 studies involving 59, 254 patients. They presented a triple algorithm for diagnosis involving epidemiological history, clinical symptoms, and laboratory/radiological findings. From New York City in the United States, Richardson et al. 8) presented a study of 5,700 patients, analyzing the clinical picture, treatments of critical disease, and outcomes. Their experience of the clinical picture of COVID-19, mild/moderate/severe disease, and diagnostic features were quite similar to Chinese experience in the initial phase of the COVID-19 pandemic.

We also reviewed experiences from other countries that were affected by COVID-19. Song et al. 9) reported their experiences in South Korea after the first case on January 20, 2020. Their main concern was delay in diagnosis, and they classified patients as susceptible, self-quarantine-susceptible, exposed, infectious with timely diagnosis, infectious with delayed diagnosis, hospitalized, recovered, or died. 9) Lum and Tambyah 10) from Singapore reported confidence in controlling COVID-19 from the previous experience of coronavirus SARS pandemic in 2003. They were prepared to diagnose COVID-19 with molecular testing RT-PCR, even before the first case was detected. 10) In a report of Furuse et al. 11) from Japan on the outbreak of COVID-19 from January to March 2020, after the first case was diagnosed on January 15, 2020, 2,175 cases tested positive, with 56 deaths. In Europe, Italy and Spain were the worst hit by COVID-19, as reported by Saglietto et al. 12) from Italy. It is still useful to read the "World Health Organization (WHO) report of the joint mission with China on coronavirus disease 2019" to obtain a broad perspective on the science of developing diagnostic studies. 13) British Medical Journal (BMJ) puts it all together on COVID-19 in a best practice series that can be read by any specialty, including pediatrics. 14) The Centers for Disease Control and Prevention (CDC) in Atlanta, Georgia, United States maintains a busy website on almost any topic on COVID-19, including evaluation and testing. 15) After a thorough review of the aforementioned literature, we studied the guidelines from national and international agencies. The Infectious Disease Society of America recommends nucleic acid testing of all symptomatic patients, individuals suspected of having contact with COVID-19 patients, or people who traveled to infected areas. They offer 15 recommendations for nucleic acid testing using an algorithmic diagram. They also have excellent guidelines for isolation, quarantine, personal protective equipment (PPE) usage, eligibility for surgery, immunosuppressive therapy, and so forth. 16) Other useful guidelines include the CDC, 17) WHO Technical Guidelines, 18) (about 3 months after the report of Fauci et al. 23) ) revealed that there were 1,761,503 cases, and 103,700 patients died. 24) Lippi et al. 25) called this a "perfect storm. " Therefore, diagnosing the disease with a molecular test and naming it COVID-19 is insufficient. We need to diagnose a "full blown disease" in this perfect storm. The diagnosis requires full knowledge of the disease, its high risk of human-to-human transmission, existence of asymptomatic carriers, viral shedding days after symptom relief requiring isolation, quarantine, environmental transmission, viral biology, pathogenesis host immunopathology, rapid progression to acute respiratory distress syndrome (ARDS), and high mortality even after intensive care. 25) Wynants et al. 26) presented an indepth systematic literature review of COVID-19 diagnosis and classified diagnostic models, including machine learning-based mortality risks and progression to severity. However, they concluded that all were poorly reported and a high risk of bias was present. 26) COVID-19 has emerged as an acute, highly infectious, and lifethreatening disease in a context of a pandemic. We diagnosed and 

The Collins English Dictionary describes acumen as the ability to make good judgment and quick decisions. 27) Merriam Webster Dictionary defines acumen as keenness and depth of perception, discernment, or discrimination especially on practice matters. 28) Considering the emergent nature of COVID-19, diagnostic acumen refers to how accurately and how quickly a physician recognizes and treats COV-

All physicians possess diagnostic acumen to assess, diagnose, and treat what we will refer to as "mainstream diseases. " The nature of CO-VID-19 requires some changes in its diagnostic elements. For example, the traditional diagnosis of a disease requires symptom recognition by person-to-person history taking, physical examination, laboratory and radiological studies, and confirmation of the disease for treatment.

COVID-19, however, may exist in the presymptomatic phase or be asymptomatic. Due to isolation and quarantine, face-to-face interactions and physical examination may not be possible. Remote consultation and video observation of the patient may be preferred if resources exist. Diagnostic experience is fragmented due to the unpredictable nature of COVID-19, along with development of "front line" providers and paramedical professionals and even medical students. Usually, diagnosis can predict prognosis for most patients with mainstream diseases but not for those with COVID-19. Diagnosis generally matches treatment for mainstream diseases. Molecular diagnostic tests and radiographic studies are not 100% accurate for COVID-19. 29) The molecular test may be specific to COVID-19, but it is not a good standard because it recognizes only viral RNA and not infectivity. A detailed discourse on laboratory tests is beyond the scope of this study, but Watson et al. 30) provide good decision making based on test results.

Patel et al. 31) gave us a very useful report from the American Society for Microbiology on the COVID-19 international summit on March 23, 2020. They responded to some challenging questions: when to test, whom to test, how often to test, and what should be done with the test results? 31) We have compared the diagnostic acumen traditionally applied to diagnose mainstream diseases with the acumen required to diagnose the complexities of COVID-19 in the context of a pandemic in Table 1 .

Time to time, clues appear in medical literature, also popularized by news media and social media, such as olfactory dysfunction, anosmia, or dysgeusia. Whitcroft and Hummel 32) best described olfactory dysfunction using diagnostic methods and even recommendations for management. Galvan Casas et al. 33) described patterns of dermatological lesions in 375 patients. 35) For the purpose of diagnostic acumen, we will call the disease simply COVID-19, with no preceding or following words.

Diagnostic acumen involves the ability of clinicians to recall past experiences and reflect on comparative features of this infectious disease in the context of a pandemic. What Greenberg et al. 36) 

The main dilemma is the diagnosis of viral shedding or infectivity. Molecular testing is accurate to the extent of viral RNA, but not infectivity.

It is of great importance for contact tracing, isolation of exposed individual social distancing, and essential public health measures to prevent further spread. Widders et al. 42) address the challenges in diagnosis.

In addition to timely diagnosis and prevention of delays, the accuracy of COVID diagnosis is critical. Gandhi and Singh 43) proposed eight categories of errors anticipated in COVID-19 diagnosis and proposed a user-friendly nomenclature: classic presentation with respiratory symptoms, anomalous/missed or delayed with non-respiratory symptoms, anchor/diagnosis on assumption, second/missed secondary diagnosis in a patient being treated for COVID-19, acute collateral/patients are not coming for evaluation due to fear of contracting infection, chronic collateral/cancelled appointments, strain/health care system overwhelmed, and unintended/less direct interaction due to telemedicine. In a pandemic like the COVID-19 pandemic, the entire population is at risk of transmission and infection. Rong et al. 44) categorized patients as susceptible, exposed, infectious with timely or de- with or without evidence-based medicine requires diagnostic acumen. Because there are so many variables and complexities, we pass them through a diagnostic analytical lens, subject them to diagnostic acumen, and arrive at the diagnosis of COVID-19 with a focus on the patient (Figure 1 ). Once the diagnosis is given, the next question is, "how bad is it?" or 

It is important for clinicians to have good knowledge about the biology of this virus, particularly to answer the patient's questions and educate An excellent review is available by Meo et al. 51) on all three coronaviruses responsible for the pandemics of this century. The complications related to the pathogenicity of COVID-19 is well described "cytokine storm" is another feature, with high fever, thrombocytopenia, hyperferritinemia and increased inflammatory marker C-reactive protein. 52) This immune response is also known as cytokine release syndrome and a hyperinflammatory response. 53) 

The hallmark of all three coronavirus pandemics is severe acute respiratory syndrome in the severe stages. In fact, the first pandemic disease was simply named "SARS. " The second pandemic disease was named MERS, dropping the terms severe and acute. In the third pandemic, the disease was named COVID-19 dropping the terms severe, acute, and respiratory syndromes. In a review by Chu et al., 54) 

It is important to keep in mind that many COVID-19 patients are elderly and suffer from non-communicable diseases requiring timely assessment and management, irrespective of COVID-19 diagnosis. 

Physicians have the "diagnostic duty" to inform of the diagnosis of CO-VID-19 and the implications of the diagnosis in a pandemic situation with highly infectious diseases such as COVID-19. Physicians may have an ethical or legal obligation to notify public health authorities of a patient's diagnosis or participation in data sharing with infectious disease registries. The American Medical Association 58) has provided excellent guidelines for physicians regarding the ethics of diagnosis of COVID-19.

Filling in a death certificate for any deceased patient requires accuracy in filling the diagnosis, and the death certificate is a document to be filled with respect to the deceased patient and the family. An accurate count of the number of deaths due to COVID-19, which depends in part on proper death certification, is critical to ongoing public health surveillance and response. Since COVID-19 is a new diagnosis, considerable confusion exists in the accurate diagnosis in death certificates. The following information obtained from the National Center for Health Statistics in the United States may be helpful for certifying death due to COVID-19. 59) Physicians may wonder if "COVID-19" is an abbreviation and whether we need a full form. However, COVID-19 is an accurate and WHO-approved name for the disease in the United States and internationally and to be written as such.

• COVID-19 is not the underlying cause of death.

• Underlying causes of death are all conditions leading to death but not the cause of death.

• Pneumonia is not the cause of death but the intermediate cause of death.

• 'Viral infection' is not specific.

• COVID-19 is the disease condition that directly preceded death.

• "Manner of death" in COVID-19 is almost always filled as "natural. "

• Do not put respiratory failure as a manner of death.

• Therefore, COVID-19 is the correct cause of death because it directly preceded death.

Patient: Yes, the patient is called upon to undergo diagnosis of COV-ID-19 first because of quarantine or everyone is advised to call the doctor. There may not be a COVID-19 diagnosis if a patient does not recognize symptoms for diagnosis, and the diagnosis may be delayed. Triage nurse: Nurses or similar professionals designated by physicians take the patient's phone call and advise the patient to stay home or make "forward triage" to go to a clinic or emergency room.

Primary care physician: May encounter COVID-19 patients initially at an early undifferentiated stage as most presenting symptoms are non-specific and cannot "clinch" the COVID-19 diagnosis.

We recommend the need to recognize "red flags" for a serious condition that carries a likelihood of immediate or impending disability or death. Red flags should be identified early, usually during the historytaking process. For example, chest pain radiating to the neck or shoulder, diaphoresis, and palpitations may indicate possible acute myocardial infarction. Standard red flags exist in many fields of medicine. Ramanayake and Basnayake 60) provide very good guidance for the evaluation of red flags and minimize missing serious diseases in primary care.

For COVID-19, the red flags are moderate or severe symptoms, particularly those related to the respiratory system, as we have seen in several reviews and guidelines. Miller 61) describes flags of other colors in chiropractic.

We believe that these may apply to mild-to-moderate state of COV-ID-19, as follows: yellow for emotional/behavior issues (isolation, quarantine), black for occupational issues (unemployment due to quarantine), and blue for social and economic circumstances (family separation, dependent elderly patients, etc.). Orange flag for psychiatric elements (anxiety, depression, and demoralization during the pandemic). Diagnostic acumen in highly infectious diseases like COV-ID-19 in the context of a pandemic first requires a high index of suspicion, which we will assign to the white flag.

Lei et al. 62) provided the best interpretations for the molecular diagnostic test RT-PCR. 

The infectivity and human-to-human transmission of COVID-19 in a matter of a few days was so powerful that even the super-powers, Europe and the United States, were overwhelmed to the verge of collapse of emergency healthcare systems. Every physician/nurse of any specialty was called upon to manage the emergency, hospital, and intensive care unit systems, who had not worked in these sites before. For example, Sarpong et al. 63) describe compassionately how an entire orthopedic department was redeployed to the hospital and emergency services.

Medical students were called upon to manage COVID-19 patients. 64) Infectious disease specialists could diagnose and treat COVID-19.

Walensky et al. 65) conducted an interesting study to examine how the distribution of infectious disease specialists matches the needs of the COVID-19 pandemic across the United States; they concluded that the availability of infectious disease physicians during pandemic times was too sparse, with 1-76 infectious disease specialists per 100,000

persons. Therefore, infectious disease diagnosis and management of COVID-19 became what we will call "front line diagnosis" in emergency management situations in the hospital. Obviously, the diagnosis in the emergency room and ICU has to be ultra-quick and focused on respiratory distress and acute organ failure, irrespective of confirmation of the diagnosis of COVID-19.

The WHO's definition of palliative care is an approach that improves the quality of life of patients and their families facing problems associated with life-threatening illness through prevention and impeccable assessment and treatment of pain and other problems, such as physical, psychosocial, and spiritual problems. 66) The WHO also has guide- 68) reported that 818 patients were admitted to inpatient wards for palliative care. Downar et al. 69) predicted a COVID-19-like pandemic and outlined a comprehensive palliative care plan for palliating a pandemic by stating that "all patients must be cared for. " We emphasize that palliative care in COVID-19 is essential to determine the diagnosis of terminal illness with great distress, lest the patient and family miss out on comforting palliative care.

It is not true that every patient with COVID-19 in the emergency room or ICU suffering from ARDS is dying. Patients may be stable, unstable, or at the end of their life. It may still be argued that palliative care can be provided with a rapidly escalating model of care in the emergency room or ICU, while a non-escalating model of care is preferred in palliative care. Fusi-Schmidhauser et al. 70) proposed and developed innovative 'emergency palliative care action' for conservative management of COVID-19 patients; they have also developed a specific diagnostic assessment tool with three 'D's: dyspnea, distress, and discomfort. The emergency style of palliative care can provide comfort for patients who are deteriorating rapidly. 70) 

The most important element in the diagnostic acumen for COVID-19

is communication skills that provide information on diagnosis to patients and their families. This is bound to evoke a fear of death and suffering. Therefore, breaking this sad and bad news requires sensitivity, sympathy, empathy, and compassion, whether face-to-face with a mask on, or through several layers of PPE or remotely by telemedicine.

Science and technology may be able to view the virus on a cell; fuse with the cell wall; enter the cell; and use the host cell apparatus to replicate itself with genes, enzymes, and proteins; but in this third coronavirus epidemic, we still need the diagnostic acumen for accurate and timely diagnosis. We still need to acquire knowledge regarding the pathogenicity, pathophysiology, immunology, and host responses to facilitate the discovery of a cure or prophylaxis. Diagnostic acumen is the most important link between etiology and treatment.

Martin and Martin-Granel 71) provide an interesting account of the evolution of the term epidemiology. Hippocrates discussed epidemics 2,300 years ago. 71) The adjective of the term is "epidemios" meaning "which circulates or propagates in a country. " It is so uncanny or ominous scientifically or a coincidence that Kelly-Cirino et al. 72) submitted their paper to BMJ Global Health before the COVID-19 pandemic in September 2018, published early in 2019, on diagnostics and preparedness in epidemic or pandemic situations. Their analysis showed that six out of ten WHO blueprint priority diseases of pandemics have significant diagnostic gaps. Wu and Lowenstein 73) emphasized that di-

Beijing: Chinese Center for Disease Control and Prevention

Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention

How will country-based mitigation measures influence the course of the COVID-19 epidemic?

Strategy for disease diagnosis, progression prediction, risk group stratification and treatment: case of COVID-19

The severe acute respiratory syndrome

Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study

Novel coronavirus infection (COV-ID-19) in humans: a scoping review and meta-analysis

Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York city area

COVID-19 in South Korea: challenges of subclinical manifestations

Outbreak of COVID-19: an urgent need for good science to silence our fears

Epidemiology of COVID-19 outbreak in Japan

COVID-19 in Europe: the Italian lesson

Report of the WHO-China joint mission on coronavirus disease 2019 (COVID-19)

Coronavirus disease 2019 (COVID-19)

CDC: COVID-19 testing: what you need to know

Centers for Disease Control and Prevention

Infectious Diseases Society of America guidelines on the treatment and management of patients with COVID-19

CDC: COVID-19 guidelines

Centers for Disease Control and Prevention

Country & technical guidance: coronavirus disease (COVID-19) [Internet]. Geneva: World Health Organization

London: National Institute for Health and Care Excellence

Coronavirus disease (COV-ID-19): a primer for emergency physicians

Review of the clinical characteristics of coronavirus disease 2019 (COVID-19)

Pandemicity and severity are separate constructs

COVID-19: navigating the uncharted

United States COVID-19 cases and deaths by state

Centers for Disease Control and Prevention

Coronavirus disease 2019 (CO-VID-19): the portrait of a perfect storm

Prediction models for diagnosis and prognosis of COVID-19: systematic review and critical appraisal

Acumen

Laboratory diagnosis of COVID-19: current issues and challenges

Interpreting a COVID-19 test result

value of diagnostic testing for SARS-CoV-2/COVID-19

Olfactory dysfunction in COVID-19: diagnosis and management

Classification of the cutaneous manifestations of COVID-19: a rapid prospective nationwide consensus study in Spain with 375 cases

World Health Organization. Coronavirus disease (COVID-19) pandemic [Internet]. Geneva: World Health Organization

The COVID-19 pandemic: a comprehensive review of taxonomy, genetics, epidemiology, diagnosis, treatment, and control

Managing mental health challenges faced by healthcare workers during COV-ID-19 pandemic

Can we contain the COVID-19 outbreak with the same measures as for SARS?

Severe acute respiratory syndrome (SARS): epidemiology, diagnosis and management

The novel zoonotic COVID-19 pandemic: an expected global health concern

Centers for Disease Control and Prevention

Middle east respiratory syndrome (MERS)

Centers for Disease Control and Prevention

SARS-CoV-2: the viral shedding vs infectivity dilemma

Reducing the risk of diagnostic error in the COV-ID-19 era

Effect of delay in diagnosis on transmission of COVID-19

Mental health and the COVID-19 pandemic

COVID-19 and long term conditions: what if you have cancer, diabetes, or chronic kidney disease?

Restricted family visiting in intensive care during COVID-19

Communicating with patients and families about difficult matters: a rapid review in the context of the COVID-19 pandemic. medRxiv

Mild or Moderate COVID-19

Coronavirus pathogenesis and the emerging pathogen severe acute respiratory syndrome coronavirus. Microbiol

Novel coronavirus 2019-nCoV: prevalence, biological and clinical characteristics comparison with SARS-CoV and MERS-CoV

Severe COVID-19

The immune system and CO-VID-19: friend or foe?

Comparative tropism, replication kinetics, and cell damage profiling of SARS-CoV-2 and SARS-CoV with implications for clinical manifestations, transmissibility, and laboratory studies of COVID-19: an observational study

Acute respiratory distress syndrome: the Berlin Definition

Molecular pathology of emerging coronavirus infections

Chronic non-communicable diseases: a sacrifice on the altar of COVID-19?

AMA code of medical ethics: guidance in a pandemic

Guidance for certifying deaths due to coronavirus disease 2019 (COVID-19)

Evaluation of red flags minimizes missing serious diseases in primary care

Know your clinical flags: 5 different colors to consider

CA): Dynamic Chiropractic

Differential diagnosis for coronavirus disease (COVID-19): beyond radiologic features

What's important: redeployment of the orthopaedic surgeon during the COVID-19 pandemic: perspectives from the trenches

The role of medical students during the COVID-19 pandemic

Where is the ID in COVID-19?

World Health Organization. WHO definition of palliative care

Clinical management of severe acute respiratory infection (SARI) when COVID-19 disease is suspected

Hospice utilization during the SARS outbreak in Taiwan

Educational Fellows in Care at the End of Life. Palliating a pandemic: "all patients must be cared for

Conservative management of COVID-19 patients-emergency palliative care in action

500-year evolution of the term epidemic

Importance of diagnostics in epidemic and pandemic preparedness

Balancing confidence and humility in the diagnostic process